Publications by authors named "Anna Halliday"

Claim this Profile
C
Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review.
Maria-Magdalena Balp, Anna C Halliday, Thomas Severin, Saoirse A Leonard, Gautam Partha

Dermatol Ther (Heidelb)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK.
Paul Emery, Marjolijn Van Keep, Steve Beard, Chris Graham, LaStella Miles, Anna Halliday

Pharmacoeconomics· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK.
Vanessa Buchanan, Will Sullivan, Chris Graham, LaStella Miles, Steffen Marc Jugl, Anna Halliday

Pharmacoeconomics· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria.
Jonathan Graham, Doreen McBride, Donald Stull, Anna Halliday, Stamatia Theodora Alexopoulos

Pharmacoeconomics· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria.
Emma Hawe, Doreen McBride, Maria-Magdalena Balp, Haijun Tian, Anna Halliday

Pharmacoeconomics· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis